Orchestra BioMed Holdings, Inc.(OBIO)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
OBIO is scheduled to report on Nov 16, 2026, usually after the market closes. Analysts expect EPS of -$0.41.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±9.3%).
Did the stock rise after good news?
The next-day move after each of its last 6 EPS beats and 3 misses.
In plain words: it beat expectations 6 times, but the stock still fell 2 of those 6 times.
- Mar '26Beat▼ -4.8%
- Nov '25Beat▲ +8.5%
- Aug '25Beat▲ +7.9%
- May '25Missed▲ +10.9%
- Mar '25Missed▼ -24.3%
- Nov '24Beat▲ +7.2%
- Aug '24Missed▼ -2.5%
- Mar '24Beat▼ -0.7%
- Nov '23Beat▲ +13.1%
Clear beats and misses with a known reaction only. What counts as a beat
Why did OBIO fall after beating earnings?
3 of OBIO's last 9 reactions went against the EPS result. What stands out in each:
OBIO beat EPS estimates in 6 quarters, and the stock still closed lower the next day 2 times.
- Mar 12, 2026EPS beat +168.4%stock -4.8% next day
- It had risen 10.3% in the 20 trading sessions before the report, so good news may already have been priced in.
- Mar 27, 2024EPS beat +5.9%stock -0.7% next day
- It opened 1.2% lower as soon as trading resumed.
Rose despite an EPS miss (1 of 3)
- May 12, 2025EPS missed -2.1%stock +10.9% next day
- It had already fallen 11.1% in the 20 trading sessions before the report, so weak results may have been expected.
- It opened 2.6% higher as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was OBIO's earnings move already priced in?
OBIO's move in the month before each of its last 10 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 10 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does OBIO hold its opening gap after earnings?
OBIO's opening move after each report and where it closed that day.
In 7 reports OBIO opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 7 times (29%), and fully reversed 2 times. Gaps up faded 1 of 4; gaps down recovered 1 of 3.
- Aug 12, 2025HeldOpened +3.2%, closed +7.9%
- May 12, 2025HeldOpened +2.6%, closed +10.9%
- Mar 31, 2025HeldOpened -9.8%, closed -24.3%
- Nov 12, 2024HeldOpened +5.8%, closed +7.2%
- Aug 12, 2024ReversedOpened +2.3%, closed -2.5%
- Mar 27, 2024HeldOpened -1.2%, closed -0.7%
- Nov 13, 2023ReversedOpened -4.0%, closed +13.1%
OBIO earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | After close | -$0.37 | -$0.37 | 0.0% | — | — |
| Mar 12, 2026 | Before open | -$0.38 | $0.26 | +168.4% | -4.78% | -1.09% |
| Nov 10, 2025 | After close | -$0.43 | -$0.40 | +7.0% | +8.47% | +10.58% |
| Aug 12, 2025 | Before open | -$0.51 | -$0.50 | +2.0% | +7.94% | +5.56% |
| May 12, 2025 | After close | -$0.48 | -$0.49 | -2.1% | +10.94% | +9.06% |
| Mar 31, 2025 | After close | -$0.42 | -$0.43 | -2.4% | -24.30% | -27.34% |
| Nov 12, 2024 | After close | -$0.44 | -$0.41 | +6.8% | +7.24% | +3.18% |
| Aug 12, 2024 | After close | -$0.40 | -$0.45 | -12.5% | -2.46% | -0.82% |
| May 13, 2024 | After close | -$0.38 | -$0.38 | 0.0% | +13.04% | +0.43% |
| Mar 27, 2024 | After close | -$0.34 | -$0.32 | +5.9% | -0.66% | -5.00% |
| Nov 13, 2023 | After close | -$0.39 | -$0.38 | +2.6% | +13.08% | +15.56% |
| Aug 10, 2023 | After close | -$0.41 | -$0.35 | +14.6% | — | — |
Consensus for the next report: EPS -$0.41, revenue $108,120.00.
OBIO Earnings FAQ
Answers computed from Orchestra BioMed Holdings, Inc.'s reported history
OBIO is scheduled to report on Nov 16, 2026, usually after the market closes. Analysts expect EPS of -$0.41.
Over the last 12 quarters with a usable EPS surprise, OBIO beat the consensus estimate 7 times (58%), missed 3 and landed in line 2.
Across its last 10 quarters with a measured reaction, OBIO moved an average of ±9.3% in the first session after reporting. It closed higher 60% of the time; the largest gain was 13.1% and the largest drop -24.3%.
OBIO fell in the first session after 2 of its last 6 EPS beats (33%). A beat that was already priced in, or weaker guidance, can send a stock lower.
Across its last 10 quarters with price data, OBIO moved an average of -2.8% in the 20 trading sessions before reporting and was higher in 50% of them. After a run-up of 3% or more (5 quarters), it fell the next day 40% of the time, averaging -0.1%. After a drop of 3% or more (5 quarters), it rose the next day 60% of the time, averaging +5.8%. This describes past reports; it is not a forecast.
In 7 reports OBIO opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 7 times (29%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · OBIO: 12 reported quarters, latest Aug 10, 2026. Information only, not investment advice.
Looking for more on OBIO?
Price charts, forecast, fundamentals and risk pages for OBIO are not on Tickzen yet. You can run a full stock analysis now.
Run the OBIO Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun